EMA Authorised: Levitra (vardenafil) — Bayer AG

View source ↗

Summary

The EMA authorised Levitra (vardenafil) from Bayer AG for the treatment of erectile dysfunction (decision date 13/01/2025).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Levitra (vardenafil)

Snippet

Status: Authorised. Therapeutic area: Erectile Dysfunction. MAH: Bayer AG. Decision date: 13/01/2025